Sulfatid
Изглед
Hemijska struktura sulfatida
| |
| Identifikacija | |
|---|---|
3D model (Jmol)
|
|
| DrugBank | |
| |
| Svojstva | |
| C48H93NO12S | |
| Molarna masa | 908,317 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Sulfatidi su klasa sulfatisanih galaktozilceramida koji se prvenstveno sintetišu u oligodendrocitima u centralnom nervnom sistemu. Sulfatidi su tip sulfolipida.[3][4]
Klinički značaj
[уреди | уреди извор]Alteracije sulfatidnog metabolizma, razmena i homeostaza su prisutni u najranijim klinički prepoznatljivim stepenima Alchajmerove bolesti i vezani su za metahromatsku leukodistrofiju (MLD).
Osobine
[уреди | уреди извор]| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 12 |
| Broj donora vodonika | 7 |
| Broj rotacionih veza | 43 |
| Particioni koeficijent[5] (ALogP) | 12,3 |
| Rastvorljivost[6] (logS, log(mol/L)) | -17,2 |
| Polarna površina[7] (PSA, Å2) | 220,7 |
Vidi još
[уреди | уреди извор]Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Michael A Lieberman; Ricer, Rick (2010). Lippincott's Illustrated Q&A Review of Biochemistry (1. Pap/Psc изд.). Lippincott Williams & Wilkins. ISBN 978-1-60547-302-4.
- ^ Huang JQ, Trasler JM, Igdoura S, Michaud J, Hanal N, Gravel RA (1997). „Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases”. Human Molecular Genetics. 6 (11): 1879—85. PMID 9302266. doi:10.1093/hmg/6.11.1879.
- ^ Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o.
- ^ Tetko, Igor V.; Tanchuk, Vsevolod Yu.; Kasheva, Tamara N.; Villa, Alessandro E. P. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- ^ Ertl, Peter; Rohde, Bernhard; Selzer, Paul (2000). „Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
[уреди | уреди извор]- Michael A Lieberman; Ricer, Rick (2010). Lippincott's Illustrated Q&A Review of Biochemistry (1. Pap/Psc изд.). Lippincott Williams & Wilkins. ISBN 978-1-60547-302-4.
Spoljašnje veze
[уреди | уреди извор]- Sulfatides на US National Library of Medicine Medical Subject Headings (MeSH)